Cart: 0,00€
X Isuu Mastodon Tiktok
  • Free Shipping for all Order of 36,30€ Spain
Cart: 0,00€

Prosper Biotech and cancer

The spin-off Prospera Biotech, born from the Miguel Hernández University of Elche, has carried out successful tests of its first formula aimed at reducing the effects of radiation dermatitis in cancer patients, chemotherapy.

Prosper Biotech and cancer Prosper Biotech and cancer

we read it for you

Prospera Biotech , a company from the Science Park of the Miguel Hernández University (PCUMH) in Elche, has carried out a successful pilot study to test a formulation that reduces sensory discomfort associated with radiotherapy in cancer patients. The formulation, called PB07, derives from Oncapsisens® cream, which reinforces the barrier function of the epidermis through neuromodulation. During the study, carried out at the Hospital Universitario de Elche, 100% of the voluntary patients reported feeling relief from discomfort with the application of the cream, without reporting adverse effects.

According to the executive director of Prospera Biotech, Marta García Escolano, radiotherapy is essential in the treatment of cancer, and almost half of the patients receive it at some point. Radiodermatitis, a radiation dermatitis , affects up to 95% of irradiated patients, negatively impacting their quality of life and adherence to treatment. In this context, finding relief for these discomforts is crucial.

The pilot study was conducted in volunteer breast cancer patients scheduled to receive radiation therapy. The formulation was applied twice a day to the irradiated area from baseline to one month after treatment. 100% of the patients who completed the study experienced relief from discomfort with the cream and no adverse effects were reported. In addition, 87% of the volunteers improved their dermatological quality of life and 80% expressed satisfaction with the state of their skin affected by radiation.

Prospera Biotech cream is considered safe according to Dr. Carlos Ortega, head of the Radiooncology Service of the General University Hospital of Elche during the study. The company, promoted by the director of IDIBE-UMH, Antonio Ferrer, is dedicated to applying neuromodulation research to develop products that improve health and well-being. Currently, they are seeking funding through a crowdfunding round to support research trials and consolidate their business model. Its innovative approach focuses on the treatment of sensitive skin through neurodermatology, acting on the skin's nerve endings at a superficial level.

The following will soon be on the market: Proctisens (care for sensitive skin in the perianal area) , Nocisens Oil ( PB07 formulation for care for skin subjected to radiotherapy) and Vulvisens (care for the female intimate area).


related products

PROSPERA BIOTECH Vulvisens 30 ml


Price: 32,84€ In offer

Reviews de Prosper Biotech and cancer

Related Manufacturers / Laboratories

By clicking on 'accept all cookies', you accept that cookies are stored on your device to improve site navigation, analyze its use, and collaborate with our marketing studies.
Cookie Settings
Accept all cookies

Privacy Preference Center

When you visit any website, it may collect or store information on your browser, generally through the use of cookies. This information may be about you, your preferences, or your device, and is used primarily to make the site work as expected. The information generally does not directly identify you, but it can provide you with a more personalized web experience. Because we respect your right to privacy, you can choose not to allow us to use certain cookies. Click on each category heading to learn more and change our default settings. However, blocking some types of cookies may affect your experience on the site and the services we can offer.

[Cookies Policy] [More information]

Allow them all

Manage consent preferences

Strictly necessary cookies Always active

These cookies are necessary for the website to function and cannot be disabled in our systems. They are usually configured to respond to actions you take to receive services, such as adjusting your privacy preferences, logging into the site, or filling out forms. You can set your browser to block or alert the presence of these cookies, but some parts of the website will not work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so that we can measure and improve the performance of our site. They help us to know which pages are the most or least popular, and to see how many people visit the site. All the information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you visited our site, and therefore we will not be able to know when you visited it.

Functionality Cookies

These cookies allow the site to offer better functionality and personalization. They may be set by us or by third parties whose services we have added to our pages. If you do not allow these cookies some of our services will not work properly. It also enables storage related to security, such as authentication functionality, fraud prevention, and other user protection.

Targeted cookies

These cookies may be throughout the website, placed by our advertising partners. These businesses may use them to build a profile of your interests and show you relevant ads on other sites. They do not store personal information directly, but are based on the unique identification of your browser and Internet access device. If you do not allow these cookies, you will have less targeted advertising.

Social network cookies

These cookies are set by a number of social networking services that we have added to the site to allow you to share our content with your friends and networks. They are able to track your browser across other sites and create a profile of your interests. This may modify the content and messages you find on other web pages you visit. If you do not allow these cookies you will not be able to see or use these sharing tools.

Confirm my preferences